| Title |
Erythropoietin or darbepoetin for patients with cancer
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2012
|
| DOI | 10.1002/14651858.cd003407.pub5 |
| Pubmed ID | |
| Authors |
Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert, Julia Bohlius |
| Abstract |
Anaemia associated with cancer and cancer therapy is an important clinical factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant human erythropoiesis stimulating agents (ESAs) and red blood cell transfusions. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | 33% |
| United Kingdom | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 381 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 2 | <1% |
| Ireland | 1 | <1% |
| Canada | 1 | <1% |
| Spain | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 375 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 53 | 14% |
| Researcher | 38 | 10% |
| Student > Bachelor | 38 | 10% |
| Student > Ph. D. Student | 37 | 10% |
| Other | 34 | 9% |
| Other | 66 | 17% |
| Unknown | 115 | 30% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 159 | 42% |
| Nursing and Health Professions | 34 | 9% |
| Biochemistry, Genetics and Molecular Biology | 12 | 3% |
| Psychology | 10 | 3% |
| Agricultural and Biological Sciences | 7 | 2% |
| Other | 33 | 9% |
| Unknown | 126 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 December 2020.
All research outputs
#2,386,096
of 25,864,668 outputs
Outputs from Cochrane database of systematic reviews
#4,792
of 13,146 outputs
Outputs of similar age
#21,478
of 288,664 outputs
Outputs of similar age from Cochrane database of systematic reviews
#68
of 194 outputs
Altmetric has tracked 25,864,668 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,146 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.3. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 288,664 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 194 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.